Company Filing History:
Years Active: 1997-2002
Title: Innovations of Hung-Teh Kao
Introduction
Hung-Teh Kao is a notable inventor based in Hackensack, NJ (US). He has made significant contributions to the field of pharmacology, particularly in the study of serotonin receptors. With a total of 3 patents, his work has implications for drug development and therapeutic applications.
Latest Patents
Kao's latest patents include innovative methods for obtaining compounds that interact with the human serotonin (5-HT2) receptor. One patent describes a method for determining whether a chemical compound binds to the human 5-HT receptor expressed on the surface of a mammalian cell. If the compound binds, it is then admixed with a carrier. Another patent focuses on DNA encoding the human serotonin (5-HT2) receptor and its various uses. This includes isolated nucleic acid molecules and vectors for expression in different cell types. Additionally, the invention provides methods for detecting the presence of the 5-HT2 receptor and screening drugs that specifically interact with it.
Career Highlights
Hung-Teh Kao has been associated with Synaptic Pharmaceutical Corporation, where he has contributed to groundbreaking research in neuroscience and pharmacology. His work has been pivotal in advancing the understanding of serotonin receptors and their role in various physiological processes.
Collaborations
Kao has collaborated with notable colleagues such as Paul R Hartig and Theresa A Branchek, enhancing the research output and innovation at Synaptic Pharmaceutical Corporation.
Conclusion
Hung-Teh Kao's contributions to the field of pharmacology through his patents and research have paved the way for advancements in drug development targeting serotonin receptors. His work continues to influence the scientific community and the development of new therapeutic strategies.